Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Cellebrite DI Ltd.CLBT · Entity 4238 | Director · Chief Executive Officer | September 24, 2026 | September 25, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Cellebrite DI Ltd.
Report date September 24, 2026 · Filed September 25, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary shares, par value NIS 0.00001SEC Table I · non-derivative | Direct | 462,055 |
Reported balance
After 2026-09-24 transaction · row 1
1 source rowRow 1 · 2026-09-24 · Grant · Acquired 38,505 · Balance 462,055 F1: Represents an award of restricted share units ("RSUs") that will vest as follows: 9,633 vest on May 4, 2027 and 2,406 vest every three months thereafter through May 4, 2030. Each RSU represents a contingent right to receive one Ordinary Share of the Issuer upon settlement. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents an award of restricted share units ("RSUs") that will vest as follows: 9,633 vest on May 4, 2027 and 2,406 vest every three months thereafter through May 4, 2030. Each RSU represents a contingent right to receive one Ordinary Share of the Issuer upon settlement.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 24, 2026 Filed Sep 25, 2026 20:05 UTC | Cellebrite DI Ltd. CLBT · Entity 4238 | GrantOrdinary shares, par value NIS 0.00001 | 38,505 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-063560 · wk-form4_1790366733.xml · nonDerivative · entry 1 Ramji Shiven · CIK 0002133891 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 462,055 F1 · shares: Represents an award of restricted share units ("RSUs") that will vest as follows: 9,633 vest on May 4, 2027 and 2,406 vest every three months thereafter through May 4, 2030. Each RSU represents a contingent right to receive one Ordinary Share of the Issuer upon settlement. Read SEC document |
| May 12, 2026 Filed May 14, 2026 20:06 UTC | Cellebrite DI Ltd. CLBT · Entity 4238 | GrantOrdinary shares, par value NIS 0.00001 | 423,550 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-035084 · wk-form4_1778789167.xml · nonDerivative · entry 1 Ramji Shiven · CIK 0002133891 · President Products & Tech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 423,550 F1 · shares: Represents an award of restricted share units ("RSUs") that will vest as follows: 105,898 vest on May 4, 2027 and 26,471 vest every three months thereafter through May 4, 2030. Each RSU represents a contingent right to receive one Ordinary Share of the Issuer upon settlement. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.